Global New Product Planning Lead

Global New Product Planning Lead (maternity cover)

Are you ready to make an impact by shaping the early-stage Research & Development pipeline and developing the portfolio analyses and business cases needed to inform decisions at senior management level? Would you like to apply your background in business and/ or science to assess business opportunities that will change the lives of millions living with Serious Chronic Diseases?

Then you may be the candidate we are looking for as our new Global Portfolio Lead in the New Product Planning (NPP) department. Join our expansion into new therapeutic areas and apply now for a life-changing career!

The position
Your key tasks will be to be commercially responsible for R&D projects across the CETA portfolio. You will work within the project team of a drug candidate to develop the target product profile and early positioning, collecting primary and secondary data on market conditions and preference shares, and shaping insights into actionable commercial recommendations.

This is a temporary position, to cover a maternity leave.

For the right candidate, this is a great opportunity to make an impact on a truly global scale by:

On a daily basis, you will work in a global context but interact primarily with headquarter functions across a diverse network of internal colleagues from Research & Development, Commercial, Global Evidence & Patient Access, Strategic Finance, and Product Supply. You will report to the Vice President of CETA EP&I, Head of New Product Planning.

You should expect up to 10 travel days per year.

Qualifications
As an ideal candidate, you have:

It is an advantage to have previous experience from working with/within Cardiovascular Disease, Chronic Kidney Disease, MASH/liver disease. Also, will be a plus some Commercial Brand Teams experience, or key functions in the drug development value chain, e.g., R&D, Medical Affairs, Regulatory Affairs, Marketing.

On the personal side, we expect you to have excellent interpersonal skills, as this position requires you to work across multiple stakeholders in the company. You have a track record of delivering in high quality and finding new ways of achieving goals. You are self-driven, proactive and innovative and inspire ways of working smarter. You strive to take team performance to a higher level and you have demonstrated the ability to work individually as well as in a team on multiple projects in parallel.

Please note that the pharmaceutical experience is mandatory for this role. Only candidates with extensive experience from working in a pharmaceutical company will be considered. Physical presence is required in our offices in Copenhagen (Søborg), Denmark. Only candidates who are willing to commute to the Copenhagen Area will be considered.

About the department
The CETA Early Portfolio & Insights (EP&I) functional area sets the commercial direction for Novo Nordisk’s future drug portfolio within Cardiovascular Disease and Emerging Therapy Areas (CETA), including also Chronic Kidney Disease, Alzheimer’s disease, and MASH/liver disease.

The EP&I area consists of departments covering New Product Planning, Competitive Intelligence, Customer Insights, and Forecasting. Within the EP&I functional area, the NPP team holds the commercial responsibility for the early portfolio of projects across CETA. In the NPP department you will join a team of seven experienced business professionals like yourself and you will work in collaboration with the broader NPP team across all of Novo Nordisk’s strategic areas. Together with our good colleagues across Novo Nordisk, we are proud to be paving the way for the long-term commercial success of our company.

In the New Product Planning department, we are dedicated to delivering top-quality commercial assessments and business cases to inform and enable critical project and portfolio decisions. While sharing a pursuit of ambitious goals we’re focused on maintaining a healthy and creative work culture and work-life balance.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. 

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.